Cardio-Oncology for the Primary Care Provider
- PMID: 37249550
- DOI: 10.2478/rjim-2023-0012
Cardio-Oncology for the Primary Care Provider
Abstract
Cardiovascular disease is a major cause of mortality among oncologic patients. As cancer therapies continue to evolve and advance, cancer survival rates have been increasing and so has the burden of cardiovascular disease within this population. For this reason, cardio-oncology plays an important role in promoting multidisciplinary care with the primary care provider, oncology, and cardiology. In this review, we discuss the roles of different providers, strategies to monitor patients receiving cardiotoxic therapies, and summarize cancer therapy class-specific toxicities. Continued collaboration among providers and ongoing research related to cardiotoxic cancer therapies will enable patients to receive maximal, evidence-based, comprehensive care.
Keywords: cardiotoxicity; cardiovascular diseases; chemotherapy; oncology; primary care.
© 2023 Nikita Jhawar et al., published by Sciendo.
Similar articles
-
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.Int J Cardiol. 2019 Apr 1;280:163-175. doi: 10.1016/j.ijcard.2019.01.038. Epub 2019 Jan 11. Int J Cardiol. 2019. PMID: 30661849 Review.
-
Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.Circ Res. 2016 Mar 18;118(6):1008-20. doi: 10.1161/CIRCRESAHA.115.303633. Circ Res. 2016. PMID: 26987914 Review.
-
The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.Semin Oncol Nurs. 2017 Nov;33(4):384-392. doi: 10.1016/j.soncn.2017.08.010. Epub 2017 Sep 21. Semin Oncol Nurs. 2017. PMID: 28941563 Review.
-
The Year in Cardio-oncology 2022.Curr Probl Cardiol. 2023 Jan;48(1):101435. doi: 10.1016/j.cpcardiol.2022.101435. Epub 2022 Sep 30. Curr Probl Cardiol. 2023. PMID: 36183977 Review.
-
Current Knowledge and Implementation of Therapeutic Strategies in Cardio-Oncology: A National Physician-Based Survey.Am J Ther. 2025 May-Jun 01;32(3):e223-e233. doi: 10.1097/MJT.0000000000001970. Am J Ther. 2025. PMID: 40338679
Cited by
-
AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring.Diagnostics (Basel). 2025 Mar 20;15(6):787. doi: 10.3390/diagnostics15060787. Diagnostics (Basel). 2025. PMID: 40150129 Free PMC article. Review.
-
Chemotherapy cardiotoxicity research in cancer patients: a bibliometric and visual analysis (1994-2024).Front Oncol. 2025 May 15;15:1502361. doi: 10.3389/fonc.2025.1502361. eCollection 2025. Front Oncol. 2025. PMID: 40444075 Free PMC article.
References
-
- MILLER KD, NOGUEIRA L, DEVASIA T, MARIOTTO AB, YABROFF KR, JEMAL A, et al. Cancer treatment and survivorship statistics , 2022. CA Cancer J Clin. 2022 Sep;72(5):409–436.
-
- MANGONE L, MANCUSO P, TARANTINI L, LAROCCA M, BISCEGLIA I, DAMATO A, et al. A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients . Cancers (Basel). 2021 Nov 24;13(23):5903.
-
- SCHINDLER M, SPYCHER BD, AMMANN RA, ANSARI M, MICHEL G, KUEHNI CE; SWISS PAEDIATRIC ONCOLOGY GROUP (SPOG). Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study. Int J Cancer. 2016 Jul 15;139(2):322–33.
-
- STRONGMAN H, GADD S, MATTHEWS A, MANSFIELD KE, STANWAY S, LYON AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases . Lancet. 2019 Sep 21;394(10203):1041–1054.
-
- PATERSON DI, WIEBE N, CHEUNG WY, MACKEY JR, PITUSKIN E, REIMAN A, et al. Incident Cardiovascular Disease Among Adults With Cancer: A Population-Based Cohort Study . JACC CardioOncol. 2022 Mar 15;4(1):85–94.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials